•
Sep 30, 2024
The Joint Q3 2024 Earnings Report
The Joint Corp. reported Q3 2024 financial results.
Key Takeaways
The Joint Corp. reported a 2% increase in revenue to $30.2 million, but net loss was $3.2 million, including $3.8 million in loss on disposition or impairment. System-wide sales increased 8% to $129.3 million.
Revenue grew 2% to $30.2 million.
Net loss was $3.2 million, including $3.8 million in loss on disposition or impairment.
Adjusted EBITDA was $2.4 million.
System-wide sales increased 8% to $129.3 million.
The Joint
The Joint
The Joint Revenue by Segment
Forward Guidance
The company adjusted its guidance to account the potential impact of ongoing consumer headwinds.
Positive Outlook
- System-wide sales are expected to be between $525 million and $535 million.
- System-wide comp sales for all clinics open 13 months or more are expected to be between 3% and 4%.
- New franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 55 and 60.
Revenue & Expenses
Visualization of income flow from segment revenue to net income